Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1987-11-25
1991-07-02
Sneed, H. M. S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
568369, 568372, 568612, 568817, 570187, C07C 4923, C07C 49297
Patent
active
050286315
ABSTRACT:
Compounds of the formula: ##STR1## useful as anti-cancer agents, anti-obesity agents, anti-hyperglycemic agents, anti-aging agents, anti-hyperglycemic agents and anti-autoimmune agents.
REFERENCES:
patent: 2833793 (1958-05-01), Dodson et al.
patent: 2847457 (1958-08-01), Johnson et al.
patent: 2911418 (1959-11-01), Johns et al.
patent: 3076023 (1963-01-01), Kaspar et al.
patent: 3148198 (1964-09-01), Goldkamp et al.
patent: 3150184 (1964-09-01), Moersch et al.
patent: 3194831 (1965-07-01), Reimann et al.
patent: 3206472 (1965-09-01), Nagata
patent: 3264345 (1966-08-01), Moersch et al.
patent: 3403167 (1968-09-01), Nagata
patent: 3471480 (1969-10-01), Fritsch et al.
patent: 3642800 (1972-02-01), Nelson et al.
patent: 3976691 (1976-08-01), Middleton et al.
patent: 4628052 (1986-12-01), Peat et al.
"D-Homo-steroids. Part I. Derivatives Monosubstituted in Ring D", Kirk et al., J. Chem. Soc. (C), 1970, pp. 1454-1460.
"A Theory for the Quantitative Calculation of the Amplitudes of Cotton Effect Curves of Ketones", Tai et al., J. Am. Chem. Soc. 88:2179 & 2185 (1965).
"Conformational Analysis. XXXVIII. The Conformations of Cxyclohexanone Rings", Chem. Abst. 61:13365h (1964).
"4-Epifriedelin and 4-Epishionone. Structure and Reflex Effect", Aoyagi et al., Chem. Abst. 78:148091 (1973).
"Acid Catalyzed Dehydration and Rearrangement of 17-Beta; 17-Alpha, Beta-Diols in the 17a-alphamethyl-D-homoandrostane Series", Monneret et al., Chem. Abst. 73:45668 (1970).
"Backbone Rearrangements of Andros-5-ene and D-Homoandrost-5-ene Novel Recemization", Kirk et al., Chem. Abst. 75:118444 (1971).
D-Homoandrostane Chem. Abst. Index Guide 1987.
Hanson et al., Perkin Transactions I, (1977), pp. 499-501.
Numazawa et al., Steroids, 32, 519-527 (1978).
Abou-Gharbia et al., Journal of Pharmaceutical Sciences, 70, 1154-1157 (1981).
Pashko et al., Carcinogenesis, 2, 717-721 (1981).
Pashko et al., Carcinogenesis, 5, 463-466 (1984).
Raineri and Levy, Biochemistry, 9, 2233-2243 (1970).
Robinson et al., J. Org. Chem, 28, 975-980 (1963).
Neef et al., J. of Org. Chem., 43, 4679-4680 (1978).
Gordon et al., Cancer Research 46, 3389-3395 (1986).
Julian et al, in JACS, 70, 3872-3876 (1948).
Ross et al. in J. Chem. Soc., 25-27 (1945).
Pelc et al. in Collection Czechoslov. Chem. Commun. 31, 1064-1071 (1966).
Klimstra et al. in Journal of Med. Chem., 9, 924-929 (1966).
Bridgeman et al. in J. Chem. Soc. C, 250-257 (1970).
Mailloux et al. in Bulletin de la Societe Chimique de France, 617-621 (1969).
Chemical Abstracts, 67, 54331k (1967).
Catsoulacos et al. in J. Org. Chem., 32, 3723-3724 (1967).
Sheppard et al. in Some Chemistry of 13-Iso-Steroids, 2551-2558 (1977).
Crabb et al. in J.C.S. Perkin I, 1041-1045 (1981).
Chemical Abstracts 92, 215616v (1980).
Bird et al, in J.C.S. Perkin I, 750-755 (1980).
Kirk et al., in J.C.S. Perkin I, 762-779 (1976).
Chemical Abstracts 79, 42723 (1973).
Denny et al, in J.C.S. Perkin I, 486-492 (1972).
Lewbart Marvin L.
Schwartz Arthur G.
Saba J.
Sneed H. M. S.
LandOfFree
Homoandrostan-17-one and homoandrosten-17-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homoandrostan-17-one and homoandrosten-17-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homoandrostan-17-one and homoandrosten-17-ones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247593